MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.460
0.00 (0.00%)
At close: Jan 16, 2026, 4:00 PM EST
1.450
-0.010 (-0.68%)
After-hours: Jan 16, 2026, 7:59 PM EST
MIRA Pharmaceuticals Market Cap
MIRA Pharmaceuticals has a market cap or net worth of $61.14 million as of January 16, 2026. Its market cap has increased by 223.84% in one year.
Market Cap
61.14M
Enterprise Value
53.60M
1-Year Change
223.84%
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since the IPO on August 3, 2023, MIRA Pharmaceuticals's market cap has decreased from $103.22M to $61.14M, a decrease of -40.77%. That is a compound annual growth rate of -19.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 61.14M | -3.31% |
| Dec 31, 2025 | 63.23M | 234.93% |
| Dec 31, 2024 | 18.88M | 21.65% |
| Dec 29, 2023 | 15.52M | -84.96% |
| Aug 3, 2023 | 103.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |